8-K Announcements
6Apr 22, 2026·SEC
Mar 3, 2026·SEC
Feb 18, 2026·SEC
RLI Corp. (RLI) fundamental analysis — strengths, weaknesses & financial health based on data analysis
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
RLI Corp. (RLI) stock price & volume — 10-year historical chart
RLI Corp. (RLI) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
RLI Corp. (RLI) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Apr 22, 2026 | $0.83vs $0.85-2.4% | $504Mvs $490M+2.9% |
| Q1 2026 | Jan 21, 2026 | $0.94vs $0.81+15.3% | $463Mvs $482M-3.8% |
| Q4 2025 | Oct 20, 2025 | $0.83vs $0.71+16.6% | $509Mvs $515M-1.2% |
| Q3 2025 | Jul 21, 2025 | $0.84vs $0.75+12.0% | $500Mvs $445M+12.2% |
RLI Corp. (RLI) competitors in Specialty and excess surplus insurers — business model, growth, and fundamentals comparison
RLI Corp. (RLI) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
RLI Corp. (RLI) annual income statement — 10-year revenue, gross profit & net income history
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 800.8M | 820.36M | 1.01B | 987.68M | 1.18B | 1.7B | 1.51B | 1.77B | 1.88B | 1.9B |
| Revenue Growth % | -2.09% | 2.44% | 22.7% | -1.88% | 19.83% | 43.47% | -10.95% | 17.09% | 6.33% | 9.54% |
| Medical Costs & Claims | 605.29M | 640.94M | 651.15M | 679.92M | 723.95M | 966.22M | 1.12B | 1.32B | 1.32B | 1.19B |
| Medical Cost Ratio % | 75.59% | 78.13% | 64.69% | 68.84% | 61.17% | 56.9% | 74.15% | 74.32% | 70.18% | 62.49% |
| Gross Profit | 195.51M▲ 0% | 179.43M▼ 8.2% | 355.47M▲ 98.1% | 307.76M▼ 13.4% | 459.6M▲ 49.3% | 731.77M▲ 59.2% | 390.87M▼ 46.6% | 454.63M▲ 16.3% | 561.42M▲ 23.5% | 712.18M▲ 0% |
| Gross Margin % | 24.41% | 21.87% | 35.31% | 31.16% | 38.83% | 43.1% | 25.85% | 25.68% | 29.82% | 37.51% |
| Gross Profit Growth % | -28.55% | -8.23% | 98.12% | -13.42% | 49.34% | 59.22% | -46.59% | 16.31% | 23.49% | - |
| Operating Expenses | 110.92M | 111.84M | 122.74M | 117.92M | 115.28M | 11.09M | 13.61M | 27.08M | 43.15M | 205.2M |
| OpEx / Revenue % | 13.85% | 13.63% | 12.19% | 11.94% | 9.74% | 0.65% | 0.9% | 1.53% | 2.29% | 10.81% |
| Depreciation & Amortization | 6.94M | 7.04M | 8.16M | 7.43M | 7.39M | 7.98M | 8.54M | 7.66M | 8.13M | 0 |
| Combined Ratio % | 89.44% | 91.76% | 76.88% | 80.78% | 70.91% | 57.56% | 75.05% | 75.85% | 72.47% | 73.3% |
| Operating Income | 84.59M▲ 0% | 67.58M▼ 20.1% | 232.73M▲ 244.4% | 189.84M▼ 18.4% | 344.32M▲ 81.4% | 720.68M▲ 109.3% | 377.26M▼ 47.7% | 427.55M▲ 13.3% | 518.27M▲ 21.2% | 506.98M▲ 0% |
| Operating Margin % | 10.56% | 8.24% | 23.12% | 19.22% | 29.09% | 42.44% | 24.95% | 24.15% | 27.53% | 26.7% |
| Operating Income Growth % | -46.15% | -20.11% | 244.38% | -18.43% | 81.37% | 109.3% | -47.65% | 13.33% | 21.22% | - |
| EBITDA | 91.53M | 74.62M | 240.9M | 197.27M | 351.71M | 728.66M | 385.81M | 435.21M | 526.4M | 512.05M |
| EBITDA Margin % | 11.43% | 9.1% | 23.93% | 19.97% | 29.72% | 42.91% | 25.52% | 24.58% | 27.96% | 26.97% |
| Interest Expense | 7.43M | 7.44M | 7.59M | 7.6M | 7.68M | 8.05M | 7.3M | 6.33M | 5.36M | 6.38M |
| Non-Operating Income | -7.43M | -7.44M | -7.59M | -7.6M | -7.68M | -8.05M | -7.3M | -6.33M | -4.05M | -5.07M |
| Pretax Income | 84.59M▲ 0% | 67.58M▼ 20.1% | 232.73M▲ 244.4% | 189.84M▼ 18.4% | 344.32M▲ 81.4% | 720.68M▲ 109.3% | 377.26M▼ 47.7% | 427.55M▲ 13.3% | 505.98M▲ 18.3% | 494.69M▲ 0% |
| Pretax Margin % | 10.56% | 8.24% | 23.12% | 19.22% | 29.09% | 42.44% | 24.95% | 24.15% | 26.88% | 26.05% |
| Income Tax | -20.44M | 3.4M | 41.09M | 32.75M | 64.97M | 137.27M | 72.65M | 81.77M | 102.64M | 99.68M |
| Effective Tax Rate % | -24.16% | 5.03% | 17.66% | 17.25% | 18.87% | 19.05% | 19.26% | 19.13% | 20.29% | 20.15% |
| Net Income | 105.03M▲ 0% | 64.18M▼ 38.9% | 191.64M▲ 198.6% | 157.09M▼ 18.0% | 279.35M▲ 77.8% | 583.41M▲ 108.8% | 304.61M▼ 47.8% | 345.78M▲ 13.5% | 403.34M▲ 16.6% | 395.01M▲ 0% |
| Net Margin % | 13.12% | 7.82% | 19.04% | 15.91% | 23.6% | 34.36% | 20.15% | 19.53% | 21.43% | 20.8% |
| Net Income Growth % | -8.61% | -38.89% | 198.61% | -18.03% | 77.83% | 108.84% | -47.79% | 13.51% | 16.65% | 40.53% |
| EPS (Diluted) | 1.18▲ 0% | 0.72▼ 39.4% | 2.12▲ 196.5% | 1.73▼ 18.4% | 3.06▲ 76.9% | 6.37▲ 108.2% | 3.31▼ 48.0% | 3.74▲ 13.0% | 4.36▲ 16.6% | 4.28▲ 0% |
| EPS Growth % | -8.88% | -39.41% | 196.5% | -18.4% | 76.88% | 108.17% | -48.04% | 12.99% | 16.58% | 40.79% |
| EPS (Basic) | 1.19 | 0.72 | 2.14 | 1.75 | 3.09 | 6.43 | 3.34 | 3.78 | 4.38 | - |
| Diluted Shares Outstanding | 89M | 89.67M | 90.51M | 90.75M | 91.42M | 91.59M | 92.15M | 92.45M | 92.22M | 92.19M |
RLI Corp. (RLI) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | 2.95B | 3.11B | 3.55B | 3.94B | 4.51B | 4.77B | 5.18B | 5.63B | 6.16B | 5.54B |
| Asset Growth % | 6.11% | 5.35% | 14.19% | 11.08% | 14.47% | 5.74% | 8.67% | 8.66% | 9.46% | 22.76% |
| Total Investment Assets | 2.16B | 2.2B | 2.62B | 2.9B | 3.25B | 3.31B | 3.7B | 74.92M | 120.56M | 4M |
| Long-Term Investments | 2.16B | 2.2B | 2.55B | 2.85B | 3.19B | 3.26B | 3.64B | 0 | 0 | 4.41B |
| Short-Term Investments | 0 | 0 | 1.98B | 2.2B | 2.41B | 2.7B | 2.99B | 74.92M | 120.56M | 386.22M |
| Total Current Assets | 2.14B | 2.19B | 0 | 0 | 0 | 0 | 0 | 114.7M | 172.13M | 435.34M |
| Cash & Equivalents | 34.25M | 41.69M | 46.2M | 62.22M | 88.8M | 22.82M | 36.42M | 39.79M | 51.56M | 49.12M |
| Receivables | 0 | 0 | 544.89M | 618.36M | 775.37M | 929.59M | 978.55M | 230.53M | 212.23M | 2.47B |
| Other Current Assets | 0 | 0 | -2.67B | -2.99B | -3.4B | -3.79B | -4.12B | -230.53M | -212.23M | -243.45M |
| Goodwill & Intangibles | 59.3M | 54.53M | 54.13M | 53.72M | 53.56M | 53.56M | 53.56M | 53.56M | 53.56M | 214.25M |
| Goodwill | 49.66M | 46.06M | 46.06M | 46.06M | 46.06M | 46.06M | 46.06M | 46.06M | 46.06M | 53.56M |
| Intangible Assets | 9.64M | 8.47M | 8.06M | 7.66M | 7.5M | 7.5M | 7.5M | 7.5M | 7.5M | 0 |
| PP&E (Net) | 55.85M | 54.69M | 53.12M | 51.41M | 52.16M | 49.57M | 46.72M | 43.17M | 40.73M | 39.81M |
| Other Assets | -1.53B | -1.42B | -2.65B | -2.95B | -3.3B | -3.36B | -3.74B | 0 | 0 | 0 |
| Total Liabilities | 2.09B | 2.3B | 2.55B | 2.8B | 3.28B | 3.59B | 3.77B | 4.11B | 4.38B | 4.61B |
| Total Debt | 148.93M | 149.12M | 149.3M | 149.49M | 199.68M | 399.73M | 200M | 100M | 100M | 347.25M |
| Net Debt | 114.68M | 107.42M | 103.1M | 87.27M | 110.87M | 376.91M | 163.58M | 60.21M | 48.44M | 298.13M |
| Long-Term Debt | 148.93M | 149.12M | 149.3M | 149.49M | 199.68M | 199.86M | 100M | 0 | 0 | 297.25M |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 199.86M | 100M | 100M | 100M | 50M |
| Total Current Liabilities | 1.94B | 2.15B | 0 | 0 | 0 | 0 | 0 | 145.43M | 129.72M | 76.8M |
| Accounts Payable | 21.62M | 22.59M | 25.69M | 42.27M | 42.85M | 61.1M | 71.51M | 44.68M | 40.58M | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 866.97M | 0 |
| Other Current Liabilities | -74.47M | -67.72M | -92.32M | -118.19M | -141.13M | -355.83M | -284.14M | -124.24M | -907.55M | 26.8M |
| Deferred Taxes | 1000K | 1000K | 1000K | 1000K | 1000K | 0 | 0 | 0 | 1000K | 53.97M |
| Other Liabilities | 0 | 0 | -206.03M | -229.72M | -283.19M | -199.86M | -100M | 4.01B | 4.23B | 4.23B |
| Total Equity | 853.6M▲ 0% | 806.84M▼ 5.5% | 995.39M▲ 23.4% | 1.14B▲ 14.1% | 1.23B▲ 8.2% | 1.18B▼ 4.2% | 1.41B▲ 20.1% | 1.52B▲ 7.7% | 1.78B▲ 16.8% | 1.8B▲ 0% |
| Equity Growth % | 3.65% | -5.48% | 23.37% | 14.12% | 8.22% | -4.23% | 20.06% | 7.67% | 16.84% | 45.47% |
| Shareholders Equity | 853.6M | 806.84M | 995.39M | 1.14B | 1.23B | 1.18B | 1.41B | 1.52B | 1.78B | 6.4B |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | 788.52M | 908.08M | 1.01B | 1.08B | 1.23B | 1.45B | 1.61B | 1.72B | 1.88B | 1.92B |
| Common Stock | 67.08M | 674K | 678K | 681K | 682K | 684K | 1.37M | 1.38M | 1.38M | 91.93M |
| Accumulated OCI | 157.92M | -14.57M | 52.47M | 108.71M | 49.83M | -229.08M | -166.3M | -173.72M | -73.99M | -113.44M |
| Return on Equity (ROE) | 12.52% | 7.73% | 21.27% | 14.74% | 23.62% | 48.48% | 23.51% | 23.56% | 24.44% | 22% |
| Return on Assets (ROA) | 3.67% | 2.12% | 5.76% | 4.2% | 6.61% | 12.58% | 6.12% | 6.4% | 6.84% | 6.6% |
| Equity / Assets | 28.96% | 25.98% | 28.07% | 28.84% | 27.27% | 24.7% | 27.29% | 27.04% | 28.86% | 32.41% |
| Debt / Equity | 0.17x | 0.18x | 0.15x | 0.13x | 0.16x | 0.34x | 0.14x | 0.07x | 0.06x | 0.06x |
| Book Value per Share | 9.59 | 9.00 | 11.00 | 12.52 | 13.45 | 12.85 | 15.34 | 16.46 | 19.28 | 19.49 |
| Tangible BV per Share | 8.92 | 8.39 | 10.40 | 11.93 | 12.86 | 12.27 | 14.76 | 15.88 | 18.70 | 18.91 |
RLI Corp. (RLI) cash flow — operating, investing & free cash flow history
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 197.53M | 217.1M | 276.92M | 263.26M | 384.9M | 250.45M | 464.26M | 560.22M | 614.22M | 614.22M |
| Operating CF Growth % | 13.22% | 9.91% | 27.55% | -4.93% | 46.21% | -34.93% | 85.37% | 20.67% | 9.64% | -31.33% |
| Operating CF / Revenue % | 24.67% | 26.46% | 27.51% | 26.65% | 32.52% | 14.75% | 30.7% | 31.64% | 32.63% | 32.35% |
| Net Income | 105.03M | 64.18M | 191.64M | 157.09M | 279.35M | 583.41M | 304.61M | 345.78M | 403.34M | 395.01M |
| Depreciation & Amortization | 6.94M | 7.04M | 8.16M | 7.43M | 7.39M | 7.98M | 8.54M | 7.66M | 8.13M | -2.31M |
| Stock-Based Compensation | 4.8M | 5.5M | 6M | 5.4M | 6M | 9M | 9M | 8M | 0 | -2M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -25.16M | 60.11M | -27.09M | -8.4M | -41.37M | -458.42M | 31.27M | 10.87M | -47.29M | 475M |
| Working Capital Changes | 105.91M | 80.27M | 98.2M | 101.74M | 133.52M | 108.47M | 110.83M | 187.91M | 250.04M | 0 |
| Cash from Investing | -81.21M | -134.21M | -184.75M | -167.99M | -274.83M | 48.88M | -211.8M | -318.87M | -362.13M | -538.33M |
| Capital Expenditures | -9.24M | -6.09M | -6.96M | -5.77M | -8.31M | -5.89M | -5.91M | 0 | -5.52M | -1.79M |
| Acquisitions | 408K | 167K | 0 | -4.53M | -8.98M | 682.85M | 14.28M | 0 | 0 | 0 |
| Purchase of Investments | -456.41M | -843.17M | -617.66M | -596.23M | -874.53M | -2.13B | -816.42M | -909.85M | -1.5B | -402.99M |
| Sale/Maturity of Investments | 400.95M | 730.24M | 460.11M | 447.06M | 620.82M | 1.51B | 620.47M | 0 | 1.14B | 322.87M |
| Other Investing | -16.92M | -15.36M | -20.25M | -8.52M | -3.82M | -2.67M | -24.23M | 590.98M | 1.32M | -456.43M |
| Cash from Financing | -110.31M | -77.02M | -76.1M | -79.26M | -83.49M | -365.31M | -238.85M | -237.98M | -240.32M | 6.86M |
| Dividends Paid | -113.81M | -83.1M | -85.59M | -87.91M | -135.33M | -364.85M | -140.09M | -235.66M | -241.56M | -242.51M |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Issued | 3.5M | 6.08M | 9.49M | 8.65M | 1.84M | -465K | 1.25M | -2.33M | 1.24M | -727K |
| Debt Issuance (Net) | 0 | 0 | 0 | 0 | 1000K | 0 | -1000K | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 250.09M |
| Net Change in Cash | 6M▲ 0% | 5.87M▼ 2.2% | 16.06M▲ 173.7% | 16.01M▼ 0.3% | 26.59M▲ 66.0% | -65.99M▼ 348.2% | 13.61M▲ 120.6% | 3.37M▼ 75.3% | 11.78M▲ 249.8% | 22.06M▲ 0% |
| Exchange Rate Effect | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash at Beginning | 18.27M | 24.27M | 30.14M | 46.2M | 62.22M | 88.8M | 22.82M | 36.42M | 39.79M | 51.56M |
| Cash at End | 24.27M | 30.14M | 46.2M | 62.22M | 88.8M | 22.82M | 36.42M | 39.79M | 51.56M | 49.12M |
| Free Cash Flow | 188.29M▲ 0% | 211.01M▲ 12.1% | 269.96M▲ 27.9% | 257.49M▼ 4.6% | 376.6M▲ 46.3% | 244.56M▼ 35.1% | 458.34M▲ 87.4% | 555.51M▲ 21.2% | 608.7M▲ 9.6% | 551.42M▲ 0% |
| FCF Growth % | 18.94% | 12.07% | 27.93% | -4.62% | 46.26% | -35.06% | 87.42% | 21.2% | 9.57% | -6.24% |
| FCF Margin % | 23.51% | 25.72% | 26.82% | 26.07% | 31.82% | 14.4% | 30.31% | 31.38% | 32.34% | 29.04% |
| FCF per Share | 2.12 | 2.35 | 2.98 | 2.84 | 4.12 | 2.67 | 4.97 | 6.01 | 6.6 | 6.6 |
RLI Corp. (RLI) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Combined Ratio | 89.44% | 91.76% | 76.88% | 80.78% | 70.91% | 57.56% | 75.05% | 75.85% | 72.47% | 73.3% |
| Medical Cost Ratio | 75.59% | 78.13% | 64.69% | 68.84% | 61.17% | 56.9% | 74.15% | 74.32% | 70.18% | 62.49% |
| Return on Equity (ROE) | 12.52% | 7.73% | 21.27% | 14.74% | 23.62% | 48.48% | 23.51% | 23.56% | 24.44% | 22% |
| Return on Assets (ROA) | 3.67% | 2.12% | 5.76% | 4.2% | 6.61% | 12.58% | 6.12% | 6.4% | 6.84% | 6.6% |
| Equity / Assets | 28.96% | 25.98% | 28.07% | 28.84% | 27.27% | 24.7% | 27.29% | 27.04% | 28.86% | 32.41% |
| Book Value / Share | 9.59 | 9 | 11 | 12.52 | 13.45 | 12.85 | 15.34 | 16.46 | 19.28 | 19.49 |
| Debt / Equity | 0.17x | 0.18x | 0.15x | 0.13x | 0.16x | 0.34x | 0.14x | 0.07x | 0.06x | 0.06x |
| Revenue Growth | -2.09% | 2.44% | 22.7% | -1.88% | 19.83% | 43.47% | -10.95% | 17.09% | 6.33% | 9.54% |
RLI Corp. (RLI) SEC filings — annual & quarterly reports (10-K, 10-Q)
Apr 22, 2026·SEC
Mar 3, 2026·SEC
Feb 18, 2026·SEC
RLI Corp. (RLI) stock FAQ — growth, dividends, profitability & financials explained
RLI Corp. (RLI) grew revenue by 6.3% over the past year. This is steady growth.
Yes, RLI Corp. (RLI) is profitable, generating $395.0M in net income for fiscal year 2025 (21.4% net margin).
Yes, RLI Corp. (RLI) pays a dividend with a yield of 5.34%. This makes it attractive for income-focused investors.
RLI Corp. (RLI) has a return on equity (ROE) of 24.4%. This is excellent, indicating efficient use of shareholder capital.
RLI Corp. (RLI) has a combined ratio of 72.5%. A ratio below 100% indicates underwriting profitability.
RLI Corp. (RLI) financial analysis — history, returns, DCA and operating performance tools
Historical returns with dividends reinvested
Dollar cost averaging vs lump sum
Yield, growth, payout safety & DRIP
EPS trends, net income & profitability
Long-term charts & historical price data
Sales growth patterns & revenue breakdown
30 years of market, efficiency and balance-sheet ratios
DCF intrinsic value, peer multiples & estimates